Page results
-
We run two separate Urogynaecology services at UCH: The Urogynaecology and Pelvic Floor Unit and The Female Pelvic Medicine and Reconstructive Surgery Unit.
-
This information is for children and young people with type 1 diabetes using a hybrid closed loop (HCL).
-
Oral medicine is the non-surgical management of patients with diseases of the oral mucosal tissues (lining of the mouth).
-
The oral and maxillofacial surgery department focuses on the delivery of care to patients with dento-alveolar needs.
-
Prosthodontics is the reconstruction and replacement of teeth damaged as a result of congenital disorders and traumatic injuries; and includes the rehabilitation of patients with tissue lost as a result of injury.
-
Visitors and staff enjoying the special performance at UCLH. The five poets and musician pictured: Madelaine Accalia, Esme Allman, Sarah McCreadie, Courtney Conrad, Thembe Mvula and Konstantinos Glynos (photo by: Alicia Clarke).
-
Information on exercise following your urogynaecological surgery
-
Information about the autogenic training service at the Royal London Hospital for Integrated Medicine.
-
Patient information written for patients undergoing a skin snips biopsy.
-
Clinical Biochemistry HSL at 60 Whitfield Street has a fully automated laboratory offering a range of routine biochemical tests to UCLH and local GPs.
File results
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer